Prehabilitation: Optimizing Patients to Improve Outcomes - Part 1
Webinar | English | 1 Hr
Image For Activity Cover
Credit Offered
No Credit Offered
Prehabilitation is a multimodal strategy involving physical exercise as well as nutritional and psychosocial interventions aimed at improving fitness in the preoperative period. It is also used to improve and support patient tolerance and outcomes from treatments such as chemotherapy, radiotherapy, and immunotherapy.

Join a multidisciplinary team of nursing and allied health professionals as they discuss how prehabilitation can be used to optimize thoracic oncology patients prior to treatment and support them throughout their journey. This is part one of a two-part series that aims to comprehensively present the key aspects of prehabilitation, including a scientific overview of benefits, organizing a program, physical conditioning and strengthening strategies prior to and during treatment, nutritional support, and psychological/motivational support.

These webinars aim to address not only the reasons why prehabilitation is pivotal to optimizing patient care and survivorship but the wider scope of its implementation in the thoracic oncology cancer pathway.
This webinar is designed to meet the educational needs of physicians, researchers, patient advocates and nurse and allied health professionals specializing in palliative care, medical oncology, radiation oncology and thoracic surgery.
Upon completion of this activity, the participants should be able to:
  • Summarize the rationale and evidence behind prehabilitation. This will include beneficial outcomes as functional capacity and reduced hospital stay.
  • Describe how to develop and design prehabilitation programs from building the right multidisciplinary team to creating patient-centered interventions.
  • Incorporate exercise for optimizing patients to treatment. This will include the intensity and choice of a combination of functional, cardiovascular, or strength training either as home-based or supervised exercises.
  • Katherine O. Kuhns, AGACNP-BC, FNP-BC, University of Pennsylvania Health System Pennsylvania, USA
  • Clarissa Mathias, MD, PhD, Medical Oncologist, NOB/Oncoclinicas and Hospital Santa Izabel, President Brazilian Society of Clinical Oncology, Chair of IAC ASCO
  • Zoe Merchant, MSc, MRCOT, Programme Lead Prehab4Cancer and Recovery Programme, Highly Specialist Occupational Therapist GM Cancer Alliance hosted by The Christie NHS Foundation Trust, Manchester Greater Manchester, United Kingdom
  • Catherine Granger, PhD, PT, FACP, Associate Professor, Physiotherapy The University of Melbourne and The Royal Melbourne Hospital Melbourne, Australia

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email:
Powered By